Unity Biotechnology Inc (UBX) Annual Balance Sheets

Annual · GAAP · USD millions
Access UBX quarterly Balance Sheets →
Looking at balance sheet data from Unity Biotechnology Inc through Dec 31 2020 provides insight into Dec 31 2024's solvency and capital structure over time.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent7.58
Marketable Securities, Current SH15.65
Cash & Short-term Investments22.00
Notes Receivable, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.04
Total Current Assets24.27
Equipment/Property/Plant Net3.46
Long-term investments0.00
Other Assets, Noncurrent9.94
Restricted Cash Current-
Restricted Cash Noncurrent0.90
Total Assets37.66
Liabilities
Accounts Payable, Current AC1.00
Accrued Liabilities, Current AC6.17
Derivative Liability, Current DE0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current2.10
Taxes Payable0.00
Deferred Revenue, Current DE0.00
Total Current Liabilities9.26
Long-term debt0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent21.91
WarrantLiabilityNoncurrent2.20
Total Liabilities31.17
Stockholders' Equity
Related Party Promissory Notes For Purchase Of Common Stock-
Employee Promissory Notes For Purchase Of Common Stock-
Common Stock Value0.00
Additional Paid In Capital Common Stock516.82
Retained Earnings / Accumulated Deficit-510.34
Accumulated Other Comprehensive Income0.00
Other Equity0.01
Common Stockholder's Equity6.49
Total Stockholder's Equity6.49
Liabilities & Stockholder's Equity37.66
4 historic quarters locked

Sign in to unlock the full Unity Biotechnology Inc balance sheet history.

About Unity Biotechnology Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: March 7, 2025
  • Source: ubx-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-035564

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License